Quantinno Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Quantinno Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,556	Closed	-$376K	–	3461
2026 Q1	$376K	Buy	17,556 +1,568	+10%	+$22.1K	﹤0.01%	2911
2025 Q4	$149K	Buy	15,988 +1,182	+8%	+$9.88K	﹤0.01%	3098
2025 Q3	$104K	Buy	14,806 +3,525	+31%	+$24.3K	﹤0.01%	2876
2025 Q2	$73.3K	Buy	+11,281	New	+$77.6K	﹤0.01%	2537

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quantinno Capital Management's DAWN Position: Q2 2026 in Review

Quantinno Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 17,556 shares — an estimated $376K sold.

Quantinno Capital Management first reported a position in DAWN in Q2 2025 and held it in 4 quarters. The position peaked at $376K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Quantinno Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Quantinno Capital Management sold 17,556 Day One Biopharmaceuticals shares in Q2 2026, an estimated $376K.
Quantinno Capital Management first reported a position in Day One Biopharmaceuticals in Q2 2025 and held it in 4 quarters.
Quantinno Capital Management's Day One Biopharmaceuticals position peaked at $376K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.